Remote CNS Field Account Specialist – Launch & Growth
OpenKrill
A complete application in a minute
Tailored resume and cover letter, ready to send.
Benefits offered by this job
Job summary
Praxis Precision Medicines is actively seeking a results-driven Account Specialist to execute in the field across a defined territory, engaging healthcare providers and driving commercial performance. This remote role supports product launches, adoption, and patient access, with cross-functional collaboration and adherence to regulations.
The position emphasizes relationship-building, field-driven insights, and a strong track record of meeting quota in CNS or specialty pharma, including hospital
Qualifications
- 5+ years of direct sales in CNS or specialty pharmaceuticals.
- Knowledge of complex patient pathways and specialist prescriber dynamics.
- Experience with product launches, including pre-launch planning and early market execution.
Responsibilities
- Execute territory business plans to achieve and exceed sales goals.
- Develop and maintain strong relationships with healthcare providers and key stakeholders.
- Drive product adoption through effective customer engagement and education.
- Navigate complex patient pathways and support access to therapy.
- Partner with Market Access, Strategic Accounts, Patient Services, and Medical teams to optimize outcomes.
- Support launch execution, including pre-launch planning and post-launch adoption strategies.
- Leverage field insights to inform strategy and improve execution.
- Maintain high level of product, disease state, and market knowledge.
Skills
Job description
Praxis Precision Medicines is actively seeking a results-driven Account Specialist to execute in the field across a defined territory, engaging healthcare providers and driving commercial performance. This remote role supports product launches, adoption, and patient access, with cross-functional collaboration and adherence to regulations.
The position emphasizes relationship-building, field-driven insights, and a strong track record of meeting quota in CNS or specialty pharma, including hospital
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
